InMed Pharmaceuticals Announces Proposed 1-for-10 Reverse Share Split

Article summary

InMed Pharmaceuticals has announced a proposed 1-for-10 reverse share split, which is contingent upon the approval of merger-related proposals at the company's upcoming annual general and special meeting.